ERBB2 and metastatic neoplasm: Ahmed et al. showed that anti-HER2 CAR T cells were able to target HER2-positive osteosarcoma cell lines in vitro and induced regression of primary tumours and metastatic tumours in xenograft mouse model thus prolonging survival [78].